Naratriptan

Current Medical Research and Opinion

Volumn 17, Issue sup1, 2001, Pages s51-53

  Massiou, H ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

5 HT1B 1D receptor agonist; Coronary disease; Efficacy; Migraine; Naratriptan; Recurrence; Tolerability

Indexed keywords

INDOLE DERIVATIVE; NARATRIPTAN; PIPERIDINE DERIVATIVE; SEROTONIN AGONIST; TRYPTAMINE DERIVATIVE;

HUMAN; MIGRAINE; REVIEW;

HUMANS; INDOLES; MIGRAINE DISORDERS; PIPERIDINES; SEROTONIN AGONISTS; TRYPTAMINES;

EID: 0035756520     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/0300799039117016     Document Type: Article

References (9)

1. Connor HE, DT Beattie. Naratriptan – pharmacology. In: Diener HC, ed. Drug Treatment of Migraine and Other Headaches. Monographs in Clinical Neuroscience. Basel: Karger, 2000: 124 – 33
2. Saxena R, Tfelt Hansen P Triptans, 5-HT1B/1D receptor agonists in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen T, Welch KMA, eds. The Headaches, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2000: 411 – 38
3. Goadsby PJ Treatment of acute migraine attacks with naratriptan. In: Diener HC, ed. Drug Treatment of Migraine and Other Headaches. Monographs in Clinical Neuroscience. Basel: Karger, 2000: 134 – 40
4. Klassen A, Elkind A, Asgharnejad M, et al., on behalf of The Naratriptan S2WA3001 Study Group. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Headache 1997; 37: 640 – 5
5. Matthew NT, Asgharnejad M, Peykamian M, Laurenza A, on behalf of The Naratriptan S2WA3003 Study Group. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, cross-over study. The Naratriptan S2WA3003 Study Group. Neurology 1997; 49: 1485 – 90
6. Havanka H, Dahlöf C, Pop PH, et al. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther 2000; 22: 970 – 80
7. Dahlöf C, Winter P, Whitehouse H, Hassani H. Randomized, double-blind, placebo-controlled comparison of oral naratriptan and oral sumatriptan in the acute treatment of migraine. Neurology 1997; 48 \(Suppl 3): A85–A86
8. Gobel H, Winter P, Boswell D, et al. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Clin Ther 2000; 22: 981 – 9
9. Heywood J, Bomhof MAM, Pradalier A, et al., on behalf of the Naratriptan Long-Term Study Group. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Cephalalgia, 2000; 20: 470 – 4